The influence of P2Y12 receptor deficiency on the platelet inhibitory activities of prasugrel in a mouse model: Evidence for specific inhibition of P2Y12 receptors by prasugrel
Masami Hashimoto(Daiichi-Sankyo (Japan)), Fumitoshi Asai(Azabu University), Taketoshi Ogawa(Biomedical Research Laboratories (United States)), Atsuhiro Sugidachi(Daiichi Sankyo (United Kingdom)), Y. Niitsu(Daiichi-Sankyo (Japan)), Joseph A. Jakubowski(Indiana Biosciences Research Institute), Takashi Isobe(Hamamatsu Photonics (United Kingdom))
Cited by 29
Related Papers
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
|Circulation|2007|882
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
|New England Journal of Medicine|2013|651
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
|Journal of the American College of Cardiology|2012|617